Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchBudesonideBudesonide (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial

Moustafa et al., Pharmaceuticals, doi:10.3390/ph18030412, NCT06657079
Mar 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Budesonide for COVID-19
19th treatment shown to reduce risk in April 2021, now with p = 0.0000011 from 15 studies, recognized in 10 countries.
No treatment is 100% effective. Protocols combine treatments.
5,500+ studies for 119 treatments. c19early.org
Non-COVID-19 RCT with 119 hospitalized patients at high risk of acute respiratory distress syndrome (ARDS) showing significantly lower rates of ARDS and mechanical ventilation with inhaled budesonide + ipratropium bromide treatment.
Moustafa et al., 14 Mar 2025, Double Blind Randomized Controlled Trial, placebo-controlled, Egypt, peer-reviewed, 6 authors, study period November 2023 - April 2024, trial NCT06657079 (history). Contact: hebatallah.ahmed@buc.edu.eg (corresponding author), pg_122660@pharm.tanta.edu.eg, ahmad.almeslamani@aau.ac.ae, sherouk.okda@pharm.dmu.edu.eg, baalsfouk@pnu.edu.sa, amira.kassem@pharm.dmu.edu.eg.
This PaperBudesonideAll
Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial
Hebatallah Ahmed Mohamed Moustafa, Faten H Elbery, Ahmad Z Al Meslamani, Sherouk M Okda, Bshra A Alsfouk, Amira B Kassem
Pharmaceuticals, doi:10.3390/ph18030412
Objectives: There is a scarcity of pharmacological treatments that efficiently address lung injury in individuals experiencing acute respiratory distress syndrome (ARDS). Early inhaled corticosteroids and ipratropium may reduce pulmonary inflammation and injury of the lungs, minimizing the risk of ARDS. Method: This is a double-blinded randomized control trial conducted on patients at risk of ARDS. Patients were randomly allocated into two groups; the intervention group (63 patients) were administered aerosolized budesonide and ipratropium bromide, and the control group (56) were administered a placebo every eight hours for five days. Alteration in oxygen saturation divided by inspired oxygen (Fio2) (S/F) after five days was the primary outcome. Secondary outcomes included ARDS occurrence, mechanical ventilation (MV) requirement, hospital stay duration, and mortality rates. Results: Of the 604 screened, only 119 patients were included. The intervention group (63 patients) S/F ratio recovered versus the fall of the control group. Both groups had similar organ dysfunction and 28-day mortality. The intervention group had significantly (p < 0.001) fewer cases developing ARDS (9.5%) and MV (9.5%) than the control group (46.4% and 35.7%, respectively). Conclusions: The administration of inhaled budesonide and ipratropium bromide improved oxygenation, as assessed by the S/F ratio, and significantly reduced the rate of ARDS development and the requirement of MV versus the control group. Larger multi-center trials including diverse patient populations are needed to validate these results.
Conflicts of Interest: The authors declare no conflicts of interest.
References
Anderson, Atkins, Bäckman, Cipolla, Clark et al., Inhaled Medicines: Past, Present, and Future, Pharmacol. Rev, doi:10.1124/pharmrev.120.000108
Artigas, Camprubí-Rimblas, Tantinyà, Bringué, Guillamat-Prats et al., Inhalation Therapies in Acute Respiratory Distress Syndrome, Ann. Transl. Med, doi:10.21037/atm.2017.07.21
Atabai, Ware, Snider, Koch, Daniel et al., Aerosolized Beta(2)-Adrenergic Agonists Achieve Therapeutic Levels in the Pulmonary Edema Fluid of Ventilated Patients with Acute Respiratory Failure, Intensive Care Med, doi:10.1007/s00134-002-1282-x
Auriemma, Zhuo, Delucchi, Deiss, Liu et al., Acute Respiratory Distress Syndrome-Attributable Mortality in Critically Ill Patients with Sepsis, Intensive Care Med, doi:10.1007/s00134-020-06010-9
Babu, Abhilash, Kandasamy, Gowri, Association between SpO 2 /FiO 2 Ratio and PaO 2 /FiO 2 Ratio in Different Modes of Oxygen Supplementation, Indian J. Crit. Care Med, doi:10.5005/jp-journals-10071-23977
Beitler, Owens, Malhotra, Unmasking a Role for Noninvasive Ventilation in Early Acute Respiratory Distress Syndrome, JAMA, doi:10.1001/jama.2016.5987
Bell, Brandenburg, Axel Buchner, Power: Statistical Power Analyses for Windows and Mac
Bellani, Laffey, Pham, Fan, Brochard et al., Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries, JAMA, doi:10.1001/jama.2016.0291
Bilan, Dastranji, Ghalehgolab Behbahani, Comparison of the Spo 2 /Fio 2 Ratio and the Pao 2 /Fio 2 Ratio in Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome, J. Cardiovasc. Thorac. Res, doi:10.15171/jcvtr.2014.06
Biondi, Jain, Fuery, Thomas, Ali et al., Relation of Ischemic Heart Disease to Outcomes in Patients with Acute Respiratory Distress Syndrome, Am. J. Cardiol, doi:10.1016/j.amjcard.2022.04.034
Blum, Nigro, Briel, Schuetz, Ullmer et al., Adjunct Prednisone Therapy for Patients with Community-Acquired Pneumonia: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial, Lancet, doi:10.1016/S0140-6736(14)62447-8
Blum, Nigro, Winzeler, Suter-Widmer, Schuetz et al., Corticosteroid Treatment for Community-Acquired Pneumonia--the STEP Trial: Study Protocol for a Randomized Controlled Trial, Trials, doi:10.1186/1745-6215-15-257
Boyle, Mac Sweeney, Mcauley, Pharmacological Treatments in ARDS; a State-of-the-Art Update, BMC Med, doi:10.1186/1741-7015-11-166
Cazzola, Page, Calzetta, Matera, Pharmacology and Therapeutics of Bronchodilators, Pharmacol. Rev, doi:10.1124/pr.111.004580
Chang, Li, Fu, Dang, Liu, Safety and Efficacy of Corticosteroids in ARDS Patients: A Systematic Review and Meta-Analysis of RCT Data, Respir. Res, doi:10.1186/s12931-022-02186-4
Chen, Janz, Shaver, Bernard, Bastarache et al., Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio 2 Ratio Compared with Pao 2 /Fio 2 Ratio, Chest, doi:10.1378/chest.15-0169
Cheung, Tansey, Tomlinson, Diaz-Granados, Matté et al., Two-Year Outcomes, Health Care Use, and Costs of Survivors of Acute Respiratory Distress Syndrome, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.200505-693OC
Confalonieri, Salton, Fabiano, Acute Respiratory Distress Syndrome, Eur. Respir. Rev, doi:10.1183/16000617.0116-2016
Dhand, Bronchodilator Therapy in Mechanically Ventilated Patients: Patient Selection and Clinical Outcomes, Respir. Care
Eisner, Thompson, Hudson, Luce, Hayden et al., Acute Respiratory Distress Syndrome Network Efficacy of Low Tidal Volume Ventilation in Patients with Different Clinical Risk Factors for Acute Lung Injury and the Acute Respiratory Distress Syndrome, Am. J. Respir. Crit. Care Med, doi:10.1164/ajrccm.164.2.2011093
Eworuke, Major, Gilbert Mcclain, National Incidence Rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS Cause-Specific Factors in the United States (2006-2014), J. Crit. Care, doi:10.1016/j.jcrc.2018.07.002
Ferguson, Fan, Camporota, Antonelli, Anzueto et al., The Berlin Definition of ARDS: An Expanded Rationale, Justification, and Supplementary Material, Intensive Care Med, doi:10.1007/s00134-012-2682-1
Festic, Bansal, Kor, Gajic, US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS) SpO 2 /FiO 2 Ratio on Hospital Admission Is an Indicator of Early Acute Respiratory Distress Syndrome Development among Patients at Risk, J. Intensive Care Med, doi:10.1177/0885066613516411
Festic, Carr, Cartin-Ceba, Hinds, Banner-Goodspeed et al., Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome, Crit. Care Med, doi:10.1097/CCM.0000000000002284
Festic, Ortiz-Diaz, Lee, Li, Kor et al., Pre-Hospital Use of Inhaled Steroids and Incidence of Acute Lung Injury among Patients at Risk, J. Crit. Care, doi:10.1016/j.jcrc.2013.08.011
Fowler, Truwit, Hite, Morris, Dewilde et al., Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial, JAMA, doi:10.1001/jama.2019.11825
Gajic, Dabbagh, Park, Adesanya, Chang et al., Early Identification of Patients at Risk of Acute Lung Injury: Evaluation of Lung Injury Prediction Score in a Multicenter Cohort Study, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201004-0549OC
Gebistorf, Karam, Wetterslev, Afshari, Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome (ARDS) in Children and Adults, Cochrane Database Syst. Rev, doi:10.1002/14651858.CD002787.pub3
Gordon, Panos, Inhaled Albuterol/Salbutamol and Ipratropium Bromide and Their Combination in the Treatment of Chronic Obstructive Pulmonary Disease, Expert Opin. Drug Metab. Toxicol, doi:10.1517/17425251003649549
Griffiths, Evans, Inhaled Nitric Oxide Therapy in Adults, N. Engl. J. Med, doi:10.1056/NEJMra051884
Gross, Ipratropium Bromide, N. Engl. J. Med, doi:10.1056/NEJM198808253190806
Heart, Lung, Institute, Clinical, Network; Ginde et al., Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients, N. Engl. J. Med, doi:10.1056/NEJMoa1911124
Heart, Lung, Institute, Clinical, Network; Truwit et al., Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMoa1401520
Herridge, Moss, Hough, Hopkins, Rice et al., Recovery and Outcomes after the Acute Respiratory Distress Syndrome (ARDS) in Patients and Their Family Caregivers, Intensive Care Med, doi:10.1007/s00134-016-4321-8
Herridge, Tansey, Matté, Tomlinson, Diaz-Granados et al., Functional Disability 5 Years after Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMoa1011802
Jansson, Eriksson, Wang, Effects of Budesonide and N-Acetylcysteine on Acute Lung Hyperinflation, Inflammation and Injury in Rats, Vasc. Pharmacol, doi:10.1016/j.vph.2005.03.006
Jiang, Wang, Liu, Ji, Zhang, The Effect of Ventilator Mask Atomization Inhalation of Ipratropium Bromide and Budesonide Suspension Liquid in the Treatment of COPD in Acute Exacerbation Period on Circulating Levels of Inflammation and Prognosis, Eur. Rev. Med. Pharmacol. Sci, doi:10.26355/eurrev_201711_13843
Ju, Gao, Huang, Niu, Lan et al., Therapeutic Effect of Inhaled Budesonide (Pulmicort ® Turbuhaler) on the Inflammatory Response to One-Lung Ventilation, Anaesthesia, doi:10.1111/anae.12479
Kassem, Ahmed, Omran, Megahed, Habib, Role of Ascorbic Acid Infusion in Critically Ill Patients with Transfusion-related Acute Lung Injury, Br. J. Clin. Pharmacol, doi:10.1111/bcp.15167
Kor, Carter, Park, Festic, Banner-Goodspeed et al., Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2016.6330
Lewis, Pritchard, Thomas, Smith, Pharmacological Agents for Adults with Acute Respiratory Distress Syndrome, Cochrane Database Syst. Rev, doi:10.1002/14651858.CD004477.pub3
Luo, Yu, Hu, Liu, Wang et al., Early Identification of Patients at Risk for Acute Respiratory Distress Syndrome among Severe Pneumonia: A Retrospective Cohort Study, J. Thorac. Dis, doi:10.21037/jtd.2017.09.20
Mangi, Bansal, Li, Pieper, Gajic et al., Pre-Hospital Use of Inhaled Corticosteroids and Inhaled Beta Agonists and Incidence of ARDS: A Population-Based Study, Acta Med. Acad, doi:10.5644/ama2006-124.138
Manthous, A Practical Approach to Adult Acute Respiratory Distress Syndrome, Indian J. Crit. Care Med, doi:10.4103/0972-5229.76084
Marik, Pastores, Annane, Meduri, Sprung et al., Recommendations for the Diagnosis and Management of Corticosteroid Insufficiency in Critically Ill Adult Patients: Consensus Statements from an International Task Force by the American College of Critical Care Medicine, Crit. Care Med, doi:10.1097/CCM.0b013e31817603ba
Marseu, Slinger, Peri-Operative Pulmonary Dysfunction and Protection, Anaesthesia, doi:10.1111/anae.13311
Matera, Cazzola, Muscarinic Receptor Antagonists, Handb. Exp. Pharmacol, doi:10.1007/164_2016_68
Matthay, Arabi, Siegel, Ware, Bos et al., Phenotypes and Personalized Medicine in the Acute Respiratory Distress Syndrome, Intensive Care Med, doi:10.1007/s00134-020-06296-9
Matthay, Brower, Carson, Douglas, Eisner et al., Randomized, Placebo-Controlled Clinical Trial of an Aerosolized B 2 -Agonist for Treatment of Acute Lung Injury, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201012-2090OC
Matthay, Folkesson, Clerici, Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema, Physiol. Rev, doi:10.1152/physrev.00003.2002
Meduri, Bridges, Shih, Marik, Siemieniuk et al., Prolonged Glucocorticoid Treatment Is Associated with Improved ARDS Outcomes: Analysis of Individual Patients' Data from Four Randomized Trials and Trial-Level Meta-Analysis of the Updated Literature, Intensive Care Med, doi:10.1007/s00134-015-4095-4
Meng, Liao, Wang, Chen, Gao et al., Pharmacologic Therapies of ARDS: From Natural Herb to Nanomedicine, Front. Pharmacol, doi:10.3389/fphar.2022.930593
Meyer, Christie, Genetic Heterogeneity and Risk of Acute Respiratory Distress Syndrome, Semin. Respir. Crit. Care Med, doi:10.1055/s-0033-1351121
Meyer, Gattinoni, Calfee, Acute Respiratory Distress Syndrome, Lancet, doi:10.1016/S0140-6736(21)00439-6
Mikkelsen, Christie, Lanken, Biester, Thompson et al., The Adult Respiratory Distress Syndrome Cognitive Outcomes Study: Long-Term Neuropsychological Function in Survivors of Acute Lung Injury, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201111-2025OC
Mohamed, Meguid, Effect of Nebulized Budesonide on Respiratory Mechanics and Oxygenation in Acute Lung Injury/Acute Respiratory Distress Syndrome: Randomized Controlled Study, Saudi J. Anaesth, doi:10.4103/1658-354X.197369
Mutlu, Factor, Alveolar Epithelial Beta2-Adrenergic Receptors, Am. J. Respir. Cell Mol. Biol, doi:10.1165/rcmb.2007-0198TR
Ok, Yildiz, Traş, Başpinar, Akar, Effect of Nebulized Formoterol, Ipratropium Bromide, and Furosemide in Combination with Fluticasone Propionate on Arterial Blood Gases of Premature Calves with Respiratory Distress Syndrome, J. Hell. Vet. Med. Soc, doi:10.12681/jhvms.22949
Ortiz-Diaz, Li, Kor, Gajic, Akca et al., Preadmission Use of Inhaled Corticosteroids Is Associated with a Reduced Risk of Direct Acute Lung Injury/Acute Respiratory Distress Syndrome, Chest, doi:10.1378/chest.1110134
Papazian, Forel, Gacouin, Penot-Ragon, Perrin et al., Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMoa1005372
Perkins, Gates, Park, Gao, Knox et al., The Beta Agonist Lung Injury Trial Prevention. A Randomized Controlled Trial, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201308-1549OC
Perkins, Mcauley, Thickett, Gao, The Beta-Agonist Lung Injury Trial (BALTI): A Randomized Placebo-Controlled Clinical Trial, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.200508-1302OC
Prescott, Calfee, Thompson, Angus, Liu, Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201512-2544CP
Ranieri, Pettilä, Karvonen, Jalkanen, Nightingale et al., Effect of Intravenous Interferon β-1a on Death and Days Free from Mechanical Ventilation Among Patients with Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2019.22525
Reilly, Christie, Primed for Injury: Cigarette Smokers and Acute Respiratory Distress Syndrome, Crit. Care Med, doi:10.1097/CCM.0000000000001121
Restrepo, Inhaled Adrenergics and Anticholinergics in Obstructive Lung Disease: Do They Enhance Mucociliary Clearance?, Respir. Care
Rice, Wheeler, Bernard, Hayden, Schoenfeld et al., National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network Comparison of the SpO 2 /FiO 2 Ratio and the PaO 2 /FiO 2 Ratio in Patients with Acute Lung Injury or ARDS, Chest, doi:10.1378/chest.07-0617
Riley, Lambert, Abo-Zaid, Meta-Analysis of Individual Participant Data: Rationale, Conduct, and Reporting, BMJ, doi:10.1136/bmj.c221
Riviello, Kiviri, Twagirumugabe, Mueller, Banner-Goodspeed et al., Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201503-0584OC
Rogliani, Calzetta, Matera, Di Daniele, Girolami et al., Inhaled Therapies and Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease, Expert Opin. Pharmacother, doi:10.1080/14656566.2019.1570133
Sheu, Gong, Zhai, Bajwa, Chen et al., The Influence of Infection Sites on Development and Mortality of ARDS, Intensive Care Med, doi:10.1007/s00134-010-1851-3
Sheu, Gong, Zhai, Chen, Bajwa et al., Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS, Chest, doi:10.1378/chest.09-2933
Siemieniuk, Meade, Alonso-Coello, Briel, Evaniew et al., Corticosteroid Therapy for Patients Hospitalized with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis, Ann. Intern. Med, doi:10.7326/M15-0715
Singh, Gladdy, Chandy, Sen, Incidence and Outcome of Acute Lung Injury and Acute Respiratory Distress Syndrome in the Surgical Intensive Care Unit, Indian J. Crit. Care Med, doi:10.4103/0972-5229.142175
Smith, Perkins, Gates, Young, Mcauley et al., BALTI-2 study investigators Effect of Intravenous β-2 Agonist Treatment on Clinical Outcomes in Acute Respiratory Distress Syndrome (BALTI-2): A Multicentre, Randomised Controlled Trial, Lancet, doi:10.1016/S0140-6736(11)61623-1
Spindler, Waschke, Beta-Adrenergic Stimulation Contributes to Maintenance of Endothelial Barrier Functions under Baseline Conditions, Microcirculation, doi:10.1111/j.1549-8719.2010.00072.x
Spragg, Bernard, Checkley, Curtis, Gajic et al., Beyond Mortality: Future Clinical Research in Acute Lung Injury, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201001-0024WS
Spragg, Lewis, Walmrath, Johannigman, Bellingan et al., Effect of Recombinant Surfactant Protein C-Based Surfactant on the Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMoa033181
Standiford, Ward, Therapeutic Targeting of Acute Lung Injury and Acute Respiratory Distress Syndrome, Transl. Res, doi:10.1016/j.trsl.2015.04.015
Stapleton, Wang, Hudson, Rubenfeld, Caldwell et al., Causes and Timing of Death in Patients with ARDS, Chest, doi:10.1378/chest.128.2.525
Steinberg, Hudson, Goodman, Hough, Lanken et al., Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMoa051693
Suda, Tsuruta, Eom, Or, Mui et al., Acute Lung Injury Induces Cardiovascular Dysfunction, Am. J. Respir. Cell Mol. Biol, doi:10.1165/rcmb.2010-0169OC
Sweet, Carnielli, Greisen, Hallman, Klebermass-Schrehof et al., European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update, Neonatology, doi:10.1159/000528914
Taylor, Zimmerman, Dellinger, Straube, Criner et al., Inhaled Nitric Oxide in ARDS Study Group Low-Dose Inhaled Nitric Oxide in Patients with Acute Lung Injury: A Randomized Controlled Trial, JAMA, doi:10.1001/jama.291.13.1603
Thompson, Chambers, Liu, Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJMra1608077
Thompson, Guérin, Esteban, Should ARDS Be Renamed Diffuse Alveolar Damage?, Intensive Care Med, doi:10.1007/s00134-016-4296-5
Torres, Sibila, Ferrer, Polverino, Menendez et al., Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2015.88
Vadi, Correlation of Oxygen Index, Oxygen Saturation Index, and PaO 2 /FiO 2 Ratio in Invasive Mechanically Ventilated Adults, Indian J. Crit. Care Med, doi:10.5005/jp-journals-10071-23506
Villar, Ferrando, Martínez, Ambrós, Muñoz et al., Dexamethasone Treatment for the Acute Respiratory Distress Syndrome: A Multicentre, Randomised Controlled Trial, Lancet Respir. Med, doi:10.1016/S2213-2600(19)30417-5
Walther, Jansson, Berg, Olsson Rex, Lennquist, Corticosteroid by Aerosol in Septic Pigs--Effects on Pulmonary Function and Oxygen Transport, Intensive Care Med, doi:10.1007/BF01720531
Wang, Zhang, Walther, Administration of Aerosolized Terbutaline and Budesonide Reduces Chlorine Gas-Induced Acute Lung Injury, J. Trauma, doi:10.1097/01.TA.0000078689.45384.8B
Wang, Zheng, Zhang, Zhu, Shi et al., Nebulized Ipratropium Bromide Protects against Tracheal and Bronchial Secretion during Bronchoscopy, Medicine, doi:10.1097/MD.0000000000017942
Ware, Matthay, Alveolar Fluid Clearance Is Impaired in the Majority of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome, Am. J. Respir. Crit. Care Med, doi:10.1164/ajrccm.163.6.2004035
Ware, Matthay, The Acute Respiratory Distress Syndrome, N. Engl. J. Med, doi:10.1056/NEJM200005043421806
Wick, Mcauley, Levitt, Beitler, Annane et al., Promises and Challenges of Personalized Medicine to Guide ARDS Therapy, Crit. Care, doi:10.1186/s13054-021-03822-z
Williams, Rubin, Clinical Pharmacology of Bronchodilator Medications, Respir. Care, doi:10.4187/respcare.06051
Xiong, Wang, Tan, Cao, Zou et al., Statins for the Prevention and Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis, Respirology, doi:10.1111/resp.12820
Yadav, Thompson, Gajic, Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?, Am. J. Respir. Crit. Care Med, doi:10.1164/rccm.201609-1767CI
Zhang, Fievez, Zhang, Cheu, Antoine et al., Effects of Formoterol and Ipratropium Bromide on Repeated Cadmium Inhalation-Induced Pulmonary Inflammation and Emphysema in Rats, Eur. J. Pharmacol, doi:10.1016/j.ejphar.2010.08.028
Zhao, Liu, Li, Aspiration-Related Acute Respiratory Distress Syndrome in Acute Stroke Patient, PLoS ONE, doi:10.1371/journal.pone.0118682
DOI record: { "DOI": "10.3390/ph18030412", "ISSN": [ "1424-8247" ], "URL": "http://dx.doi.org/10.3390/ph18030412", "abstract": "<jats:p>Objectives: There is a scarcity of pharmacological treatments that efficiently address lung injury in individuals experiencing acute respiratory distress syndrome (ARDS). Early inhaled corticosteroids and ipratropium may reduce pulmonary inflammation and injury of the lungs, minimizing the risk of ARDS. Method: This is a double-blinded randomized control trial conducted on patients at risk of ARDS. Patients were randomly allocated into two groups; the intervention group (63 patients) were administered aerosolized budesonide and ipratropium bromide, and the control group (56) were administered a placebo every eight hours for five days. Alteration in oxygen saturation divided by inspired oxygen (Fio2) (S/F) after five days was the primary outcome. Secondary outcomes included ARDS occurrence, mechanical ventilation (MV) requirement, hospital stay duration, and mortality rates. Results: Of the 604 screened, only 119 patients were included. The intervention group (63 patients) S/F ratio recovered versus the fall of the control group. Both groups had similar organ dysfunction and 28-day mortality. The intervention group had significantly (p &lt; 0.001) fewer cases developing ARDS (9.5%) and MV (9.5%) than the control group (46.4% and 35.7%, respectively). Conclusions: The administration of inhaled budesonide and ipratropium bromide improved oxygenation, as assessed by the S/F ratio, and significantly reduced the rate of ARDS development and the requirement of MV versus the control group. Larger multi-center trials including diverse patient populations are needed to validate these results.</jats:p>", "alternative-id": [ "ph18030412" ], "author": [ { "ORCID": "https://orcid.org/0000-0003-4530-406X", "affiliation": [ { "name": "Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt" } ], "authenticated-orcid": false, "family": "Moustafa", "given": "Hebatallah Ahmed Mohamed", "sequence": "first" }, { "affiliation": [ { "name": "Department of Clinical Pharmacy, Faculty of Pharmacy, Al Salam University, Kafr Alzayat 31611, Algharbia, Egypt" } ], "family": "Elbery", "given": "Faten H.", "sequence": "additional" }, { "affiliation": [ { "name": "College of Pharmacy, Al Ain University, Abu Dhabi P.O. Box 112612, United Arab Emirates" }, { "name": "AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi P.O. Box 112612, United Arab Emirate" } ], "family": "Al Meslamani", "given": "Ahmad Z.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0005-7322-7219", "affiliation": [ { "name": "Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour 22514, Egypt" } ], "authenticated-orcid": false, "family": "Okda", "given": "Sherouk M.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-6489-6035", "affiliation": [ { "name": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia" } ], "authenticated-orcid": false, "family": "Alsfouk", "given": "Bshra A.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4195-6036", "affiliation": [ { "name": "Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour 22514, Egypt" } ], "authenticated-orcid": false, "family": "Kassem", "given": "Amira B.", "sequence": "additional" } ], "container-title": "Pharmaceuticals", "container-title-short": "Pharmaceuticals", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 3, 14 ] ], "date-time": "2025-03-14T17:07:51Z", "timestamp": 1741972071000 }, "deposited": { "date-parts": [ [ 2025, 3, 17 ] ], "date-time": "2025-03-17T12:05:59Z", "timestamp": 1742213159000 }, "funder": [ { "DOI": "10.13039/501100004242", "award": [ "PNURSP2025R142" ], "doi-asserted-by": "crossref", "id": [ { "asserted-by": "crossref", "id": "10.13039/501100004242", "id-type": "DOI" } ], "name": "Princess Nourah bint Abdulrahman University" } ], "indexed": { "date-parts": [ [ 2025, 3, 17 ] ], "date-time": "2025-03-17T12:40:28Z", "timestamp": 1742215228005, "version": "3.38.0" }, "is-referenced-by-count": 0, "issue": "3", "issued": { "date-parts": [ [ 2025, 3, 14 ] ] }, "journal-issue": { "issue": "3", "published-online": { "date-parts": [ [ 2025, 3 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 3, 14 ] ], "date-time": "2025-03-14T00:00:00Z", "timestamp": 1741910400000 } } ], "link": [ { "URL": "https://www.mdpi.com/1424-8247/18/3/412/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1968", "original-title": [], "page": "412", "prefix": "10.3390", "published": { "date-parts": [ [ 2025, 3, 14 ] ] }, "published-online": { "date-parts": [ [ 2025, 3, 14 ] ] }, "publisher": "MDPI AG", "reference": [ { "DOI": "10.1001/jama.2016.0291", "article-title": "Epidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries", "author": "Bellani", "doi-asserted-by": "crossref", "first-page": "788", "journal-title": "JAMA", "key": "ref_1", "volume": "315", "year": "2016" }, { "DOI": "10.1055/s-0033-1351121", "article-title": "Genetic Heterogeneity and Risk of Acute Respiratory Distress Syndrome", "author": "Meyer", "doi-asserted-by": "crossref", "first-page": "459", "journal-title": "Semin. Respir. Crit. Care Med.", "key": "ref_2", "volume": "34", "year": "2013" }, { "DOI": "10.4103/0972-5229.142175", "article-title": "Incidence and Outcome of Acute Lung Injury and Acute Respiratory Distress Syndrome in the Surgical Intensive Care Unit", "author": "Singh", "doi-asserted-by": "crossref", "first-page": "659", "journal-title": "Indian J. Crit. Care Med.", "key": "ref_3", "volume": "18", "year": "2014" }, { "DOI": "10.21037/atm.2017.07.21", "article-title": "Inhalation Therapies in Acute Respiratory Distress Syndrome", "author": "Artigas", "doi-asserted-by": "crossref", "first-page": "293", "journal-title": "Ann. Transl. Med.", "key": "ref_4", "volume": "5", "year": "2017" }, { "DOI": "10.1056/NEJM200005043421806", "article-title": "The Acute Respiratory Distress Syndrome", "author": "Ware", "doi-asserted-by": "crossref", "first-page": "1334", "journal-title": "N. Engl. J. Med.", "key": "ref_5", "volume": "342", "year": "2000" }, { "DOI": "10.1016/S0140-6736(21)00439-6", "article-title": "Acute Respiratory Distress Syndrome", "author": "Meyer", "doi-asserted-by": "crossref", "first-page": "622", "journal-title": "Lancet", "key": "ref_6", "volume": "398", "year": "2021" }, { "DOI": "10.1378/chest.15-0169", "article-title": "Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio2 Ratio Compared with Pao2/Fio2 Ratio", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "1477", "journal-title": "Chest", "key": "ref_7", "volume": "148", "year": "2015" }, { "DOI": "10.1007/s00134-012-2682-1", "article-title": "The Berlin Definition of ARDS: An Expanded Rationale, Justification, and Supplementary Material", "author": "Ferguson", "doi-asserted-by": "crossref", "first-page": "1573", "journal-title": "Intensive Care Med.", "key": "ref_8", "volume": "38", "year": "2012" }, { "DOI": "10.4103/0972-5229.76084", "article-title": "A Practical Approach to Adult Acute Respiratory Distress Syndrome", "author": "Manthous", "doi-asserted-by": "crossref", "first-page": "196", "journal-title": "Indian J. Crit. Care Med.", "key": "ref_9", "volume": "14", "year": "2010" }, { "DOI": "10.1007/s00134-020-06296-9", "article-title": "Phenotypes and Personalized Medicine in the Acute Respiratory Distress Syndrome", "author": "Matthay", "doi-asserted-by": "crossref", "first-page": "2136", "journal-title": "Intensive Care Med.", "key": "ref_10", "volume": "46", "year": "2020" }, { "DOI": "10.1164/rccm.201004-0549OC", "article-title": "Early Identification of Patients at Risk of Acute Lung Injury: Evaluation of Lung Injury Prediction Score in a Multicenter Cohort Study", "author": "Gajic", "doi-asserted-by": "crossref", "first-page": "462", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_11", "volume": "183", "year": "2011" }, { "DOI": "10.5005/jp-journals-10071-23977", "article-title": "Association between SpO2/FiO2 Ratio and PaO2/FiO2 Ratio in Different Modes of Oxygen Supplementation", "author": "Babu", "doi-asserted-by": "crossref", "first-page": "1001", "journal-title": "Indian J. Crit. Care Med.", "key": "ref_12", "volume": "25", "year": "2021" }, { "DOI": "10.15171/jcvtr.2014.06", "article-title": "Comparison of the Spo2/Fio2 Ratio and the Pao2/Fio2 Ratio in Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome", "author": "Bilan", "doi-asserted-by": "crossref", "first-page": "28", "journal-title": "J. Cardiovasc. Thorac. Res.", "key": "ref_13", "volume": "7", "year": "2015" }, { "DOI": "10.1177/0885066613516411", "article-title": "US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS) SpO2/FiO2 Ratio on Hospital Admission Is an Indicator of Early Acute Respiratory Distress Syndrome Development among Patients at Risk", "author": "Festic", "doi-asserted-by": "crossref", "first-page": "209", "journal-title": "J. Intensive Care Med.", "key": "ref_14", "volume": "30", "year": "2015" }, { "DOI": "10.5005/jp-journals-10071-23506", "article-title": "Correlation of Oxygen Index, Oxygen Saturation Index, and PaO2/FiO2 Ratio in Invasive Mechanically Ventilated Adults", "author": "Vadi", "doi-asserted-by": "crossref", "first-page": "54", "journal-title": "Indian J. Crit. Care Med.", "key": "ref_15", "volume": "25", "year": "2021" }, { "DOI": "10.1378/chest.128.2.525", "article-title": "Causes and Timing of Death in Patients with ARDS", "author": "Stapleton", "doi-asserted-by": "crossref", "first-page": "525", "journal-title": "Chest", "key": "ref_16", "volume": "128", "year": "2005" }, { "DOI": "10.1007/s00134-016-4296-5", "article-title": "Should ARDS Be Renamed Diffuse Alveolar Damage?", "author": "Thompson", "doi-asserted-by": "crossref", "first-page": "653", "journal-title": "Intensive Care Med.", "key": "ref_17", "volume": "42", "year": "2016" }, { "DOI": "10.1164/rccm.200505-693OC", "article-title": "Two-Year Outcomes, Health Care Use, and Costs of Survivors of Acute Respiratory Distress Syndrome", "author": "Cheung", "doi-asserted-by": "crossref", "first-page": "538", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_18", "volume": "174", "year": "2006" }, { "DOI": "10.1056/NEJMoa1011802", "article-title": "Functional Disability 5 Years after Acute Respiratory Distress Syndrome", "author": "Herridge", "doi-asserted-by": "crossref", "first-page": "1293", "journal-title": "N. Engl. J. Med.", "key": "ref_19", "volume": "364", "year": "2011" }, { "DOI": "10.1007/s00134-016-4321-8", "article-title": "Recovery and Outcomes after the Acute Respiratory Distress Syndrome (ARDS) in Patients and Their Family Caregivers", "author": "Herridge", "doi-asserted-by": "crossref", "first-page": "725", "journal-title": "Intensive Care Med.", "key": "ref_20", "volume": "42", "year": "2016" }, { "DOI": "10.1164/rccm.201111-2025OC", "article-title": "The Adult Respiratory Distress Syndrome Cognitive Outcomes Study: Long-Term Neuropsychological Function in Survivors of Acute Lung Injury", "author": "Mikkelsen", "doi-asserted-by": "crossref", "first-page": "1307", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_21", "volume": "185", "year": "2012" }, { "DOI": "10.1164/rccm.201503-0584OC", "article-title": "Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition", "author": "Riviello", "doi-asserted-by": "crossref", "first-page": "52", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_22", "volume": "193", "year": "2016" }, { "DOI": "10.1056/NEJMra1608077", "article-title": "Acute Respiratory Distress Syndrome", "author": "Thompson", "doi-asserted-by": "crossref", "first-page": "562", "journal-title": "N. Engl. J. Med.", "key": "ref_23", "volume": "377", "year": "2017" }, { "DOI": "10.1001/jama.2016.5987", "article-title": "Unmasking a Role for Noninvasive Ventilation in Early Acute Respiratory Distress Syndrome", "author": "Beitler", "doi-asserted-by": "crossref", "first-page": "2401", "journal-title": "JAMA", "key": "ref_24", "volume": "315", "year": "2016" }, { "DOI": "10.1007/s00134-015-4095-4", "article-title": "Prolonged Glucocorticoid Treatment Is Associated with Improved ARDS Outcomes: Analysis of Individual Patients’ Data from Four Randomized Trials and Trial-Level Meta-Analysis of the Updated Literature", "author": "Meduri", "doi-asserted-by": "crossref", "first-page": "829", "journal-title": "Intensive Care Med.", "key": "ref_25", "volume": "42", "year": "2016" }, { "DOI": "10.1186/s13054-021-03822-z", "article-title": "Promises and Challenges of Personalized Medicine to Guide ARDS Therapy", "author": "Wick", "doi-asserted-by": "crossref", "first-page": "404", "journal-title": "Crit. Care", "key": "ref_26", "volume": "25", "year": "2021" }, { "DOI": "10.1183/16000617.0116-2016", "doi-asserted-by": "crossref", "key": "ref_27", "unstructured": "Confalonieri, M., Salton, F., and Fabiano, F. (2017). Acute Respiratory Distress Syndrome. Eur. Respir. Rev., 26." }, { "DOI": "10.1056/NEJMoa1005372", "article-title": "Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome", "author": "Papazian", "doi-asserted-by": "crossref", "first-page": "1107", "journal-title": "N. Engl. J. Med.", "key": "ref_28", "volume": "363", "year": "2010" }, { "DOI": "10.1159/000528914", "article-title": "European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update", "author": "Sweet", "doi-asserted-by": "crossref", "first-page": "3", "journal-title": "Neonatology", "key": "ref_29", "volume": "120", "year": "2023" }, { "DOI": "10.1002/14651858.CD002787.pub3", "doi-asserted-by": "crossref", "key": "ref_30", "unstructured": "Gebistorf, F., Karam, O., Wetterslev, J., and Afshari, A. (2016). Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome (ARDS) in Children and Adults. Cochrane Database Syst. Rev., 2016." }, { "DOI": "10.3389/fphar.2022.930593", "doi-asserted-by": "crossref", "key": "ref_31", "unstructured": "Meng, L., Liao, X., Wang, Y., Chen, L., Gao, W., Wang, M., Dai, H., Yan, N., Gao, Y., and Wu, X. (2022). Pharmacologic Therapies of ARDS: From Natural Herb to Nanomedicine. Front. Pharmacol., 13." }, { "DOI": "10.1056/NEJMoa1401520", "doi-asserted-by": "crossref", "key": "ref_32", "unstructured": "National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Truwit, J.D., Bernard, G.R., Steingrub, J., Matthay, M.A., Liu, K.D., Albertson, T.E., Brower, R.G., Shanholtz, C., and Rock, P. (2014). Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome. N. Engl. J. Med., 370, 2191–2200." }, { "DOI": "10.1056/NEJMoa033181", "article-title": "Effect of Recombinant Surfactant Protein C-Based Surfactant on the Acute Respiratory Distress Syndrome", "author": "Spragg", "doi-asserted-by": "crossref", "first-page": "884", "journal-title": "N. Engl. J. Med.", "key": "ref_33", "volume": "351", "year": "2004" }, { "DOI": "10.1016/j.trsl.2015.04.015", "article-title": "Therapeutic Targeting of Acute Lung Injury and Acute Respiratory Distress Syndrome", "author": "Standiford", "doi-asserted-by": "crossref", "first-page": "183", "journal-title": "Transl. Res.", "key": "ref_34", "volume": "167", "year": "2016" }, { "DOI": "10.1001/jama.291.13.1603", "article-title": "Inhaled Nitric Oxide in ARDS Study Group Low-Dose Inhaled Nitric Oxide in Patients with Acute Lung Injury: A Randomized Controlled Trial", "author": "Taylor", "doi-asserted-by": "crossref", "first-page": "1603", "journal-title": "JAMA", "key": "ref_35", "volume": "291", "year": "2004" }, { "DOI": "10.1002/14651858.CD004477.pub3", "doi-asserted-by": "crossref", "key": "ref_36", "unstructured": "Lewis, S.R., Pritchard, M.W., Thomas, C.M., and Smith, A.F. (2019). Pharmacological Agents for Adults with Acute Respiratory Distress Syndrome. Cochrane Database Syst. Rev., 7." }, { "DOI": "10.1186/1741-7015-11-166", "doi-asserted-by": "crossref", "key": "ref_37", "unstructured": "Boyle, A.J., Mac Sweeney, R., and McAuley, D.F. (2013). Pharmacological Treatments in ARDS; a State-of-the-Art Update. BMC Med., 11." }, { "DOI": "10.1001/jama.2016.6330", "article-title": "Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial", "author": "Kor", "doi-asserted-by": "crossref", "first-page": "2406", "journal-title": "JAMA", "key": "ref_38", "volume": "315", "year": "2016" }, { "DOI": "10.1056/NEJMoa1911124", "doi-asserted-by": "crossref", "key": "ref_39", "unstructured": "National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Ginde, A.A., Brower, R.G., Caterino, J.M., Finck, L., Banner-Goodspeed, V.M., Grissom, C.K., Hayden, D., Hough, C.L., and Hyzy, R.C. (2019). Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. N. Engl. J. Med., 381, 2529–2540." }, { "DOI": "10.1001/jama.2019.22525", "article-title": "Effect of Intravenous Interferon β-1a on Death and Days Free from Mechanical Ventilation Among Patients with Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial", "author": "Ranieri", "doi-asserted-by": "crossref", "first-page": "725", "journal-title": "JAMA", "key": "ref_40", "volume": "323", "year": "2020" }, { "DOI": "10.1111/resp.12820", "article-title": "Statins for the Prevention and Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis", "author": "Xiong", "doi-asserted-by": "crossref", "first-page": "1026", "journal-title": "Respirology", "key": "ref_41", "volume": "21", "year": "2016" }, { "DOI": "10.1164/ajrccm.163.6.2004035", "article-title": "Alveolar Fluid Clearance Is Impaired in the Majority of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome", "author": "Ware", "doi-asserted-by": "crossref", "first-page": "1376", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_42", "volume": "163", "year": "2001" }, { "DOI": "10.1007/s00134-002-1282-x", "article-title": "Aerosolized Beta(2)-Adrenergic Agonists Achieve Therapeutic Levels in the Pulmonary Edema Fluid of Ventilated Patients with Acute Respiratory Failure", "author": "Atabai", "doi-asserted-by": "crossref", "first-page": "705", "journal-title": "Intensive Care Med.", "key": "ref_43", "volume": "28", "year": "2002" }, { "DOI": "10.1152/physrev.00003.2002", "article-title": "Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema", "author": "Matthay", "doi-asserted-by": "crossref", "first-page": "569", "journal-title": "Physiol. Rev.", "key": "ref_44", "volume": "82", "year": "2002" }, { "DOI": "10.1165/rcmb.2007-0198TR", "article-title": "Alveolar Epithelial Beta2-Adrenergic Receptors", "author": "Mutlu", "doi-asserted-by": "crossref", "first-page": "127", "journal-title": "Am. J. Respir. Cell Mol. Biol.", "key": "ref_45", "volume": "38", "year": "2008" }, { "DOI": "10.1164/rccm.200508-1302OC", "article-title": "The Beta-Agonist Lung Injury Trial (BALTI): A Randomized Placebo-Controlled Clinical Trial", "author": "Perkins", "doi-asserted-by": "crossref", "first-page": "281", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_46", "volume": "173", "year": "2006" }, { "article-title": "Inhaled Adrenergics and Anticholinergics in Obstructive Lung Disease: Do They Enhance Mucociliary Clearance?", "author": "Restrepo", "first-page": "1159", "journal-title": "Respir. Care", "key": "ref_47", "volume": "52", "year": "2007" }, { "DOI": "10.1111/j.1549-8719.2010.00072.x", "article-title": "Beta-Adrenergic Stimulation Contributes to Maintenance of Endothelial Barrier Functions under Baseline Conditions", "author": "Spindler", "doi-asserted-by": "crossref", "first-page": "118", "journal-title": "Microcirculation", "key": "ref_48", "volume": "18", "year": "2011" }, { "DOI": "10.1097/CCM.0000000000002284", "article-title": "Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome", "author": "Festic", "doi-asserted-by": "crossref", "first-page": "798", "journal-title": "Crit. Care Med.", "key": "ref_49", "volume": "45", "year": "2017" }, { "DOI": "10.1164/rccm.201308-1549OC", "article-title": "The Beta Agonist Lung Injury Trial Prevention. A Randomized Controlled Trial", "author": "Perkins", "doi-asserted-by": "crossref", "first-page": "674", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_50", "volume": "189", "year": "2014" }, { "DOI": "10.1016/S0140-6736(11)61623-1", "article-title": "BALTI-2 study investigators Effect of Intravenous β-2 Agonist Treatment on Clinical Outcomes in Acute Respiratory Distress Syndrome (BALTI-2): A Multicentre, Randomised Controlled Trial", "author": "Perkins", "doi-asserted-by": "crossref", "first-page": "229", "journal-title": "Lancet", "key": "ref_51", "volume": "379", "year": "2012" }, { "DOI": "10.1164/rccm.201012-2090OC", "doi-asserted-by": "crossref", "key": "ref_52", "unstructured": "National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay, M.A., Brower, R.G., Carson, S., Douglas, I.S., Eisner, M., Hite, D., Holets, S., Kallet, R.H., and Liu, K.D. (2011). Randomized, Placebo-Controlled Clinical Trial of an Aerosolized Β2-Agonist for Treatment of Acute Lung Injury. Am. J. Respir. Crit. Care Med., 184, 561–568." }, { "DOI": "10.1186/1745-6215-15-257", "article-title": "Corticosteroid Treatment for Community-Acquired Pneumonia--the STEP Trial: Study Protocol for a Randomized Controlled Trial", "author": "Blum", "doi-asserted-by": "crossref", "first-page": "257", "journal-title": "Trials", "key": "ref_53", "volume": "15", "year": "2014" }, { "DOI": "10.7326/M15-0715", "article-title": "Corticosteroid Therapy for Patients Hospitalized with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis", "author": "Siemieniuk", "doi-asserted-by": "crossref", "first-page": "519", "journal-title": "Ann. Intern. Med.", "key": "ref_54", "volume": "163", "year": "2015" }, { "DOI": "10.1001/jama.2015.88", "article-title": "Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial", "author": "Torres", "doi-asserted-by": "crossref", "first-page": "677", "journal-title": "JAMA", "key": "ref_55", "volume": "313", "year": "2015" }, { "DOI": "10.1186/s12931-022-02186-4", "article-title": "Safety and Efficacy of Corticosteroids in ARDS Patients: A Systematic Review and Meta-Analysis of RCT Data", "author": "Chang", "doi-asserted-by": "crossref", "first-page": "301", "journal-title": "Respir. Res.", "key": "ref_56", "volume": "23", "year": "2022" }, { "DOI": "10.1056/NEJMoa051693", "article-title": "Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome", "author": "Steinberg", "doi-asserted-by": "crossref", "first-page": "1671", "journal-title": "N. Engl. J. Med.", "key": "ref_57", "volume": "354", "year": "2006" }, { "DOI": "10.1016/S2213-2600(19)30417-5", "article-title": "Dexamethasone Treatment for the Acute Respiratory Distress Syndrome: A Multicentre, Randomised Controlled Trial", "author": "Villar", "doi-asserted-by": "crossref", "first-page": "267", "journal-title": "Lancet Respir. Med.", "key": "ref_58", "volume": "8", "year": "2020" }, { "DOI": "10.1097/CCM.0b013e31817603ba", "article-title": "Recommendations for the Diagnosis and Management of Corticosteroid Insufficiency in Critically Ill Adult Patients: Consensus Statements from an International Task Force by the American College of Critical Care Medicine", "author": "Marik", "doi-asserted-by": "crossref", "first-page": "1937", "journal-title": "Crit. Care Med.", "key": "ref_59", "volume": "36", "year": "2008" }, { "DOI": "10.1016/j.vph.2005.03.006", "article-title": "Effects of Budesonide and N-Acetylcysteine on Acute Lung Hyperinflation, Inflammation and Injury in Rats", "author": "Jansson", "doi-asserted-by": "crossref", "first-page": "101", "journal-title": "Vasc. Pharmacol.", "key": "ref_60", "volume": "43", "year": "2005" }, { "DOI": "10.1097/01.TA.0000078689.45384.8B", "article-title": "Administration of Aerosolized Terbutaline and Budesonide Reduces Chlorine Gas-Induced Acute Lung Injury", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "850", "journal-title": "J. Trauma", "key": "ref_61", "volume": "56", "year": "2004" }, { "DOI": "10.1111/anae.12479", "article-title": "Therapeutic Effect of Inhaled Budesonide (Pulmicort® Turbuhaler) on the Inflammatory Response to One-Lung Ventilation", "author": "Ju", "doi-asserted-by": "crossref", "first-page": "14", "journal-title": "Anaesthesia", "key": "ref_62", "volume": "69", "year": "2014" }, { "DOI": "10.1016/j.jcrc.2013.08.011", "article-title": "Pre-Hospital Use of Inhaled Steroids and Incidence of Acute Lung Injury among Patients at Risk", "author": "Festic", "doi-asserted-by": "crossref", "first-page": "985", "journal-title": "J. Crit. Care", "key": "ref_63", "volume": "28", "year": "2013" }, { "DOI": "10.5644/ama2006-124.138", "article-title": "Pre-Hospital Use of Inhaled Corticosteroids and Inhaled Beta Agonists and Incidence of ARDS: A Population-Based Study", "author": "Mangi", "doi-asserted-by": "crossref", "first-page": "109", "journal-title": "Acta Med. Acad.", "key": "ref_64", "volume": "44", "year": "2015" }, { "DOI": "10.1124/pharmrev.120.000108", "article-title": "Inhaled Medicines: Past, Present, and Future", "author": "Anderson", "doi-asserted-by": "crossref", "first-page": "48", "journal-title": "Pharmacol. Rev.", "key": "ref_65", "volume": "74", "year": "2022" }, { "DOI": "10.1124/pr.111.004580", "article-title": "Pharmacology and Therapeutics of Bronchodilators", "author": "Cazzola", "doi-asserted-by": "crossref", "first-page": "450", "journal-title": "Pharmacol. Rev.", "key": "ref_66", "volume": "64", "year": "2012" }, { "DOI": "10.1056/NEJM198808253190806", "article-title": "Ipratropium Bromide", "author": "Gross", "doi-asserted-by": "crossref", "first-page": "486", "journal-title": "N. Engl. J. Med.", "key": "ref_67", "volume": "319", "year": "1988" }, { "DOI": "10.1517/17425251003649549", "article-title": "Inhaled Albuterol/Salbutamol and Ipratropium Bromide and Their Combination in the Treatment of Chronic Obstructive Pulmonary Disease", "author": "Gordon", "doi-asserted-by": "crossref", "first-page": "381", "journal-title": "Expert Opin. Drug Metab. Toxicol.", "key": "ref_68", "volume": "6", "year": "2010" }, { "article-title": "The Effect of Ventilator Mask Atomization Inhalation of Ipratropium Bromide and Budesonide Suspension Liquid in the Treatment of COPD in Acute Exacerbation Period on Circulating Levels of Inflammation and Prognosis", "author": "Jiang", "first-page": "5211", "journal-title": "Eur. Rev. Med. Pharmacol. Sci.", "key": "ref_69", "volume": "21", "year": "2017" }, { "DOI": "10.1111/anae.13311", "article-title": "Peri-Operative Pulmonary Dysfunction and Protection", "author": "Marseu", "doi-asserted-by": "crossref", "first-page": "46", "journal-title": "Anaesthesia", "key": "ref_70", "volume": "71", "year": "2016" }, { "DOI": "10.1097/MD.0000000000017942", "doi-asserted-by": "crossref", "key": "ref_71", "unstructured": "Wang, F., Zheng, H., Zhang, Y., Zhu, H., Shi, J., Luo, Y., Zhang, X., Mao, H., Herth, F.J.F., and Luo, F. (2019). Nebulized Ipratropium Bromide Protects against Tracheal and Bronchial Secretion during Bronchoscopy. Medicine, 98." }, { "DOI": "10.1016/j.ejphar.2010.08.028", "article-title": "Effects of Formoterol and Ipratropium Bromide on Repeated Cadmium Inhalation-Induced Pulmonary Inflammation and Emphysema in Rats", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "178", "journal-title": "Eur. J. Pharmacol.", "key": "ref_72", "volume": "647", "year": "2010" }, { "article-title": "Bronchodilator Therapy in Mechanically Ventilated Patients: Patient Selection and Clinical Outcomes", "author": "Dhand", "first-page": "152", "journal-title": "Respir. Care", "key": "ref_73", "volume": "52", "year": "2007" }, { "DOI": "10.4187/respcare.06051", "article-title": "Clinical Pharmacology of Bronchodilator Medications", "author": "Williams", "doi-asserted-by": "crossref", "first-page": "641", "journal-title": "Respir. Care", "key": "ref_74", "volume": "63", "year": "2018" }, { "DOI": "10.1080/14656566.2019.1570133", "article-title": "Inhaled Therapies and Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease", "author": "Rogliani", "doi-asserted-by": "crossref", "first-page": "737", "journal-title": "Expert Opin. Pharmacother.", "key": "ref_75", "volume": "20", "year": "2019" }, { "DOI": "10.1007/164_2016_68", "article-title": "Muscarinic Receptor Antagonists", "author": "Matera", "doi-asserted-by": "crossref", "first-page": "41", "journal-title": "Handb. Exp. Pharmacol.", "key": "ref_76", "volume": "237", "year": "2017" }, { "DOI": "10.12681/jhvms.22949", "article-title": "Effect of Nebulized Formoterol, Ipratropium Bromide, and Furosemide in Combination with Fluticasone Propionate on Arterial Blood Gases of Premature Calves with Respiratory Distress Syndrome", "author": "Ok", "doi-asserted-by": "crossref", "first-page": "2011", "journal-title": "J. Hell. Vet. Med. Soc.", "key": "ref_77", "volume": "71", "year": "2020" }, { "DOI": "10.1164/rccm.201001-0024WS", "article-title": "Beyond Mortality: Future Clinical Research in Acute Lung Injury", "author": "Spragg", "doi-asserted-by": "crossref", "first-page": "1121", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_78", "volume": "181", "year": "2010" }, { "DOI": "10.1378/chest.07-0617", "article-title": "National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network Comparison of the SpO2/FiO2 Ratio and the PaO2/FiO2 Ratio in Patients with Acute Lung Injury or ARDS", "author": "Rice", "doi-asserted-by": "crossref", "first-page": "410", "journal-title": "Chest", "key": "ref_79", "volume": "132", "year": "2007" }, { "DOI": "10.1007/s00134-020-06010-9", "article-title": "Acute Respiratory Distress Syndrome-Attributable Mortality in Critically Ill Patients with Sepsis", "author": "Auriemma", "doi-asserted-by": "crossref", "first-page": "1222", "journal-title": "Intensive Care Med.", "key": "ref_80", "volume": "46", "year": "2020" }, { "DOI": "10.4103/1658-354X.197369", "article-title": "Effect of Nebulized Budesonide on Respiratory Mechanics and Oxygenation in Acute Lung Injury/Acute Respiratory Distress Syndrome: Randomized Controlled Study", "author": "Mohamed", "doi-asserted-by": "crossref", "first-page": "9", "journal-title": "Saudi J. Anaesth.", "key": "ref_81", "volume": "11", "year": "2017" }, { "DOI": "10.1164/rccm.201609-1767CI", "article-title": "Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?", "author": "Yadav", "doi-asserted-by": "crossref", "first-page": "725", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_82", "volume": "195", "year": "2017" }, { "DOI": "10.1378/chest.1110134", "doi-asserted-by": "crossref", "key": "ref_83", "unstructured": "Ortiz-Diaz, E., Li, G., Kor, D., Gajic, O., Akca, O., Adesanya, A., Hoth, J., and Festic, E. (2011). Preadmission Use of Inhaled Corticosteroids Is Associated with a Reduced Risk of Direct Acute Lung Injury/Acute Respiratory Distress Syndrome. Chest, 140." }, { "DOI": "10.1056/NEJMoa2021436", "doi-asserted-by": "crossref", "key": "ref_84", "unstructured": "RECOVERY Collaborative Group (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693–704." }, { "DOI": "10.1056/NEJMra051884", "article-title": "Inhaled Nitric Oxide Therapy in Adults", "author": "Griffiths", "doi-asserted-by": "crossref", "first-page": "2683", "journal-title": "N. Engl. J. Med.", "key": "ref_85", "volume": "353", "year": "2005" }, { "DOI": "10.1136/bmj.c221", "doi-asserted-by": "crossref", "key": "ref_86", "unstructured": "Riley, R.D., Lambert, P.C., and Abo-Zaid, G. (2010). Meta-Analysis of Individual Participant Data: Rationale, Conduct, and Reporting. BMJ, 340." }, { "DOI": "10.1111/bcp.15167", "article-title": "Role of Ascorbic Acid Infusion in Critically Ill Patients with Transfusion-related Acute Lung Injury", "author": "Kassem", "doi-asserted-by": "crossref", "first-page": "2327", "journal-title": "Br. J. Clin. Pharmacol.", "key": "ref_87", "volume": "88", "year": "2022" }, { "DOI": "10.1001/jama.2019.11825", "article-title": "Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial", "author": "Fowler", "doi-asserted-by": "crossref", "first-page": "1261", "journal-title": "JAMA", "key": "ref_88", "volume": "322", "year": "2019" }, { "DOI": "10.1097/CCM.0000000000001121", "article-title": "Primed for Injury: Cigarette Smokers and Acute Respiratory Distress Syndrome", "author": "Reilly", "doi-asserted-by": "crossref", "first-page": "2015", "journal-title": "Crit. Care Med.", "key": "ref_89", "volume": "43", "year": "2015" }, { "DOI": "10.1164/ajrccm.164.2.2011093", "article-title": "Acute Respiratory Distress Syndrome Network Efficacy of Low Tidal Volume Ventilation in Patients with Different Clinical Risk Factors for Acute Lung Injury and the Acute Respiratory Distress Syndrome", "author": "Eisner", "doi-asserted-by": "crossref", "first-page": "231", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_90", "volume": "164", "year": "2001" }, { "DOI": "10.1016/j.jcrc.2018.07.002", "article-title": "National Incidence Rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS Cause-Specific Factors in the United States (2006–2014)", "author": "Eworuke", "doi-asserted-by": "crossref", "first-page": "192", "journal-title": "J. Crit. Care", "key": "ref_91", "volume": "47", "year": "2018" }, { "DOI": "10.1378/chest.09-2933", "article-title": "Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS", "author": "Sheu", "doi-asserted-by": "crossref", "first-page": "559", "journal-title": "Chest", "key": "ref_92", "volume": "138", "year": "2010" }, { "DOI": "10.21037/jtd.2017.09.20", "article-title": "Early Identification of Patients at Risk for Acute Respiratory Distress Syndrome among Severe Pneumonia: A Retrospective Cohort Study", "author": "Luo", "doi-asserted-by": "crossref", "first-page": "3979", "journal-title": "J. Thorac. Dis.", "key": "ref_93", "volume": "9", "year": "2017" }, { "DOI": "10.1371/journal.pone.0118682", "doi-asserted-by": "crossref", "key": "ref_94", "unstructured": "Zhao, J., Liu, Y., and Li, H. (2015). Aspiration-Related Acute Respiratory Distress Syndrome in Acute Stroke Patient. PLoS ONE, 10." }, { "DOI": "10.1007/s00134-010-1851-3", "article-title": "The Influence of Infection Sites on Development and Mortality of ARDS", "author": "Sheu", "doi-asserted-by": "crossref", "first-page": "963", "journal-title": "Intensive Care Med.", "key": "ref_95", "volume": "36", "year": "2010" }, { "DOI": "10.1164/rccm.201512-2544CP", "article-title": "Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design", "author": "Prescott", "doi-asserted-by": "crossref", "first-page": "147", "journal-title": "Am. J. Respir. Crit. Care Med.", "key": "ref_96", "volume": "194", "year": "2016" }, { "DOI": "10.1016/j.amjcard.2022.04.034", "article-title": "Relation of Ischemic Heart Disease to Outcomes in Patients with Acute Respiratory Distress Syndrome", "author": "Biondi", "doi-asserted-by": "crossref", "first-page": "24", "journal-title": "Am. J. Cardiol.", "key": "ref_97", "volume": "176", "year": "2022" }, { "DOI": "10.1165/rcmb.2010-0169OC", "article-title": "Acute Lung Injury Induces Cardiovascular Dysfunction", "author": "Suda", "doi-asserted-by": "crossref", "first-page": "510", "journal-title": "Am. J. Respir. Cell Mol. Biol.", "key": "ref_98", "volume": "45", "year": "2011" }, { "DOI": "10.1007/BF01720531", "article-title": "Corticosteroid by Aerosol in Septic Pigs--Effects on Pulmonary Function and Oxygen Transport", "author": "Walther", "doi-asserted-by": "crossref", "first-page": "155", "journal-title": "Intensive Care Med.", "key": "ref_99", "volume": "19", "year": "1993" }, { "DOI": "10.1016/S0140-6736(14)62447-8", "article-title": "Adjunct Prednisone Therapy for Patients with Community-Acquired Pneumonia: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial", "author": "Blum", "doi-asserted-by": "crossref", "first-page": "1511", "journal-title": "Lancet", "key": "ref_100", "volume": "385", "year": "2015" }, { "key": "ref_101", "unstructured": "(2024, June 15). Research Randomizer. Available online: https://randomizer.org/." }, { "key": "ref_102", "unstructured": "Bell, R., Brandenburg, N., and Axel Buchner, J.H. (2023, June 30). G*Power: Statistical Power Analyses for Windows and Mac. Available online: https://www.psychologie.hhu.de/arbeitsgruppen/allgemeine-psychologie-und-arbeitspsychologie/gpower." } ], "reference-count": 102, "references-count": 102, "relation": {}, "resource": { "primary": { "URL": "https://www.mdpi.com/1424-8247/18/3/412" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial", "type": "journal-article", "volume": "18" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit